Short answer
The safest approach is to treat raw DNA as context, not certainty: check file quality, separate strong evidence from weak associations, add family and health context, keep sensitive topics opt-in, and confirm important findings clinically.
Start with the file and its limits
Different providers and chip versions cover different markers. A careful interpretation starts by checking whether the file is readable, whether enough markers are present, and which findings are too thin to report usefully.
Separate signal from noise
Raw DNA can generate long lists of possible associations. A safer report should rank findings by evidence strength, personal relevance, and practical next step, while keeping uncertain or low-action findings visibly separate.
Add the context DNA cannot know
Family history, symptoms, medications, labs, screening status, ancestry context, and personal goals change what a genetic signal means. Without that context, a report can easily overstate or understate importance.
Keep boundaries explicit
The report should not diagnose disease, predict individual outcomes, or tell you to start, stop, or change medication. Sensitive areas should be opt-in and framed as context for review.
Common questions
Should every genetic association be shown?
No. Showing everything can make weak or irrelevant associations look more important than they are. Useful interpretation prioritizes and labels uncertainty.
When should a finding be confirmed?
When a finding could affect screening, treatment, medication choice, or family planning, clinical confirmation and professional review may be appropriate.